Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world, International, Multicentre, Non-interventional, Prospective Cohort to Assess Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo in Routine Care Settings

NCT07069829 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07069829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07069829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world, International, Multicentre, Non-interventional, Prospective Cohort to Assess Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo in Routine Care Settings
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
December 15, 2025
Completion date
September 30, 2027
Enrollment
1,400 (estimated)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease